Health TrialsbyHealthPanel

A Single-center Study on the Effect of Systemic/Selective Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With Components With Consolidation/Tumor Ratio Between 0.5-1

ConditionsProgressionPostoperative Recovery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age25-75
SponsorShanghai Zhongshan Hospital

About this trial

A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5-1

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1.Aged between 25 and 75 years;

2. GGO is diagnosed by thin-section lung CT (thickness <1.5mm) within one month before surgery;

3. The maximum diameter of the GGO is smaller than 3cm;

4. The solid component in GGO between 50%-100%;

Disqualifiers

1. Patients with a history of lung surgery;

2. Postoperative pathology showed non-primary lung cancer;

3. The scope of surgical resection is larger than one lung lobe;

4. Patients with a history of other tumors;

Trial design

Design model

Parallel

Treatments tested in this trial

  • selective lymph node dissection

    Other intervention

    selective lymph node dissection

  • Systemic Lymph Node Dissection

    Other intervention

    Systemic Lymph Node Dissection

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: systemic lymph node dissection groupActive comparator 1 intervention
Group B: selective lymph node dissectionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Overall survival

Time frame
From enrollment to 36 months after surgery

Secondary outcomes

1

Complications

The degrees of cough

Time frame
1-2 Weeks after enrollment (after Surgery)

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Shanghai Zhongshan Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: